Kobayashi Pharmaceutical Co., Ltd.

TSE:4967.T

5530 (JPY) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q3
Revenue 36,65136,48554,34045,49040,15833,46751,97943,01538,61832,64647,59440,60636,78330,26945,46538,86934,26931,91150,26344,15939,89533,73551,71143,09038,96333,71549,10840,34636,55830,74937,59936,76732,60341,03933,59829,97131,19038,62631,35727,17131,56737,47931,03927,20826,70436,57530,17428,07928,43038,71334,15729,86628,17038,10833,51130,73826,76138,56033,18730,57226,86137,89932,295
Cost of Revenue 17,20615,87927,83519,87716,99514,13925,00618,58716,32814,00622,22916,81914,95312,47721,45816,03814,06313,68921,65016,41614,19112,44821,77516,24713,89912,43821,13515,36713,29011,44614,94513,95814,16617,68813,69511,96914,17617,09112,89310,55814,34516,39512,71410,73912,01416,16512,39511,15811,82116,74814,23611,83012,26116,72714,11412,78612,68017,14414,45412,91512,31717,76014,471
Gross Profit 19,44520,60626,50525,61323,16319,32826,97324,42822,29018,64025,36523,78721,83017,79224,00722,83120,20618,22228,61327,74325,70421,28729,93626,84325,06421,27727,97324,97923,26819,30322,65422,80918,43723,35119,90318,00217,01421,53518,46416,61317,22221,08418,32516,46914,69020,41017,77916,92116,60921,96519,92118,03615,90921,38119,39717,95214,08121,41618,73317,65714,54420,13917,824
Gross Profit Ratio 0.5310.5650.4880.5630.5770.5780.5190.5680.5770.5710.5330.5860.5930.5880.5280.5870.590.5710.5690.6280.6440.6310.5790.6230.6430.6310.570.6190.6360.6280.6030.620.5660.5690.5920.6010.5450.5580.5890.6110.5460.5630.590.6050.550.5580.5890.6030.5840.5670.5830.6040.5650.5610.5790.5840.5260.5550.5640.5780.5410.5310.552
Reseach & Development Expenses 2,2141,9302,7722,1612,2561,8152,6562,0161,9631,6922,3421,7541,8761,5507,3380007,1100007,0310007,239000005,7880005,2890004,9300004,5440004,38500000000000000
General & Administrative Expenses 00-11,331000-10,427000-10,406000-17,593000-28,711000-27,527000-26,19700000-21,735000-19,420000-18,671000-19,088000-19,12200000000000000
Selling & Marketing Expenses 0027,74200026,58400026,59000026,00900042,27100042,02500039,3380000031,27600026,72200026,52100025,65000027,28600000000000000
SG&A 12,78813,64716,41114,19615,30012,20016,15713,32615,08611,93116,18412,65814,21511,3448,41613,56614,88413,38313,56018,86819,57015,99914,49818,88319,02915,70913,14118,19117,86514,343009,54116,06314,96813,5497,30214,54313,83313,2857,85014,64213,64412,5266,56214,03313,09313,3688,16415,9340000000000000
Other Expenses 93192-2562217614,26619,04915,54717,26613,79518,7206891801211346869317392943-85-119111,049-178-481,326-103-236-11-70-47-108-77118818510446693229435645671136152238745954999-47597940-181-6925-42-248
Operating Expenses 15,00215,57719,18316,63217,81714,26619,04915,54717,26613,79518,72014,60116,27913,10217,57313,53614,86013,34722,54818,86819,57015,99923,20218,88319,02915,70922,19018,19117,86514,34318,09315,50916,84716,06314,96813,54914,04214,54313,83313,28514,15914,64213,64412,52612,39514,03313,09313,3687,16115,93414,65812,5877,60815,10613,52713,2566,57915,07013,58412,9296,82913,90813,149
Operating Income 4,4435,0297,3228,9815,3455,0617,9208,8815,0234,8456,6399,1865,5514,6896,4289,2955,3454,8756,0598,8756,1345,2876,7267,9616,0355,5675,7766,7865,4054,9584,5627,2991,5857,2884,9344,4532,9676,9924,6313,3273,0586,4414,6803,9432,2886,3774,6863,5539,4486,0315,2635,4488,5816,4365,8274,7047,7316,4994,8876,3327,6436,0814,675
Operating Income Ratio 0.1210.1380.1350.1970.1330.1510.1520.2060.130.1480.1390.2260.1510.1550.1410.2390.1560.1530.1210.2010.1540.1570.130.1850.1550.1650.1180.1680.1480.1610.1210.1990.0490.1780.1470.1490.0950.1810.1480.1220.0970.1720.1510.1450.0860.1740.1550.1270.3320.1560.1540.1820.3050.1690.1740.1530.2890.1690.1470.2070.2850.160.145
Total Other Income Expenses Net -3,774-3,443-9011,09262336-340629740252105669310487-65668659171-7641,049239-75-1,1851,075-711-164263-18-455-143-434-719-5091,436-449171,069814-13269635219-42732-9983844492,114-5,833-94-541100-12,224-32-113-1-7,287-125-162-3,322-6,778328-350
Income Before Tax 6691,5866,42110,0735,9685,0977,5809,5105,7635,0976,7449,8555,8615,1765,7729,9815,9364,9465,2959,9246,3735,2125,5419,0365,3245,4036,0396,7684,9504,8154,1286,5801,0768,7244,4854,4704,0367,8064,6183,5963,6936,6604,6384,6751,2906,7615,1355,6673,6155,9374,7225,548-3,6436,4045,7144,7034446,3744,7253,0108656,4094,325
Income Before Tax Ratio 0.0180.0430.1180.2210.1490.1520.1460.2210.1490.1560.1420.2430.1590.1710.1270.2570.1730.1550.1050.2250.160.1540.1070.210.1370.160.1230.1680.1350.1570.110.1790.0330.2130.1330.1490.1290.2020.1470.1320.1170.1780.1490.1720.0480.1850.170.2020.1270.1530.1380.186-0.1290.1680.1710.1530.0170.1650.1420.0980.0320.1690.134
Income Tax Expense 2086101,5832,4401,7091,4892,0572,7101,5361,6241,9112,8531,6081,5481,8252,9411,4601,2041,4012,8811,8541,5291,5262,6571,5151,5821,9172,0641,3681,3601,2491,379722,2761,3641,5882,2612,5861,5821,1791,6362,3651,6481,7117192,2751,7991,8831,3622,6141,9742,146-2,9812,6812,1721,9692562,6752,0792927952,5971,959
Net Income 4609764,8407,6344,2563,6085,5226,8004,2273,4734,8327,0024,2533,6283,9477,0404,4763,7423,8947,0434,5193,6834,0146,3803,8083,8214,1234,7033,5823,4552,8905,2191,0126,4403,1302,8841,7765,2183,0372,4172,0584,2962,9892,9645704,4863,3373,7832,2533,3232,7483,402-6623,7233,5412,7331873,6992,6452,717713,8122,366
Net Income Ratio 0.0130.0270.0890.1680.1060.1080.1060.1580.1090.1060.1020.1720.1160.120.0870.1810.1310.1170.0770.1590.1130.1090.0780.1480.0980.1130.0840.1170.0980.1120.0770.1420.0310.1570.0930.0960.0570.1350.0970.0890.0650.1150.0960.1090.0210.1230.1110.1350.0790.0860.080.114-0.0240.0980.1060.0890.0070.0960.080.0890.0030.1010.073
EPS 6.1913.1364.48100.2855.9147.4372.648854.744.8645.9289.5854.4146.4250.590.0757.2647.8749.8290.1157.2446.6550.8480.848.2348.3952.2159.5645.4643.8435.9764.9712.679.0838.4435.4221.8163.8437.1629.5725.1852.4636.536.196.9654.7840.7546.1927.5140.5733.5541.54-8.0845.4643.2433.372.2845.1732.333.180.8746.5528.89
EPS Diluted 6.1913.1364.48100.2855.9147.4372.0687.8554.6144.8644.989.5854.4146.4250.590.0757.2647.8749.8290.1157.2446.6550.8480.848.2348.3452.2159.5645.4643.8135.9764.9212.679.0838.4435.4221.8163.8437.1629.5725.1852.4636.536.196.9654.7840.7546.1927.5140.5733.5541.54-8.0845.4643.2433.372.2845.1732.333.180.8746.5528.89
EBITDA 6,5126,8159,0899,7236,0445,2207,8839,5905,8365,1527,0269,9565,9345,2316,73210,0455,6985,0856,5579,8166,4205,2236,9049,0696,1175,4197,3406,7575,3964,8554,5037,1491,4107,3734,5644,6363,0967,3504,8143,6053,2646,6744,6724,1772,7127,1325,0493,8069,8046,2355,4045,5839,6617,4726,8645,7068,8387,5785,9807,3098,7517,1444,450
EBITDA Ratio 0.1780.1870.1670.2140.1510.1560.1520.2230.1510.1580.1480.2450.1610.1730.1480.2580.1660.1590.130.2220.1610.1550.1340.210.1570.1610.1490.1670.1480.1580.120.1940.0430.180.1360.1550.0990.190.1540.1330.1030.1780.1510.1540.1020.1950.1670.1360.3450.1610.1580.1870.3430.1960.2050.1860.330.1970.180.2390.3260.1890.138